Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results

Transplant Proc. 1992 Oct;24(5):1732-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Graft Rejection / therapy*
  • Humans
  • Kidney Transplantation / immunology*
  • Male
  • Muromonab-CD3 / adverse effects
  • Muromonab-CD3 / therapeutic use*
  • Prednisone / therapeutic use
  • Prospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Muromonab-CD3
  • Azathioprine
  • Prednisone